Letter

Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: Why were patients at major risk excluded?

BMJ 2005; 331 doi: 10.1136/bmj.331.7530.1474-a (Published 15 December 2005)
Cite this as: BMJ 2005;331:1474.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Luca Puccetti, president (lucpucce@promedgalileo.org)
  1. Promed Galileo Medical Association, Pisa 56011, Italy

    EDITOR—One of the strongest risk factors for gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs (NSAIDs) is known to be previous events. Hippisley-Cox et al excluded patients who had already had a diagnosis of an adverse upper gastrointestinal event before the study period.1 This removes patients at high risk from …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular